Sinclair Pharmaceuticals, a small drug company, has developed a vaccine that will protect against Helicobacter pylori, a bacterium that is the cause of a number of diseases of the stomach. It is expected that Sinclair Pharmaceuticals will experience extremely high growth over the next three years & will reinvest all of its earnings in expanding the company over this time. Earnings were $1.65 per share before the development of the vaccine (in year 0) & are expected to grow by 40% per year for the next three years. After this time, it is expected that growth will drop to 6% & stay there for the expected future. Four years from now Sinclair will begin paying dividends that are equal to 75% of its earnings. If its equity cost of capital is 12%, what is the value of a share of Sinclair Pharmaceuticals today?